INGRAM ROBERT ALEXANDER

Director at VALEANT PHARMACEUTICALS INTERNATIONAL · on record since Jan 31, 2006
Director at OSI PHARMACEUTICALS INC · on record since Mar 20, 2006
Director at WACHOVIA CORP NEW · on record since Mar 16, 2006
Director at ALLERGAN INC · on record since Jan 5, 2006
Director at NORTEL NETWORKS CORP · on record since Jan 4, 2006
Director at LOWES COMPANIES INC · on record since Jan 3, 2006
Director at Edwards Lifesciences Corp · on record since May 15, 2006
Director at WOLFSPEED, INC. · on record since Dec 31, 2008
Director at PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC · on record since May 19, 2011
Director at QUINTILES TRANSNATIONAL CORP · on record since Feb 11, 2004
Director at REGENERON PHARMACEUTICALS, INC. · on record since Apr 8, 2014
Director at BIOCRYST PHARMACEUTICALS INC · on record since Aug 11, 2015
10% owner at Clearside Biomedical, Inc. · on record since Jun 7, 2016
Director at NVN Liquidation, Inc. · on record since Sep 28, 2016
10% owner at G1 Therapeutics, Inc. · on record since May 24, 2017
10% owner at PhaseBio Pharmaceuticals Inc · on record since Oct 24, 2018
Director at Black Diamond Therapeutics, Inc. · on record since Sep 29, 2020
FORMER DIRECTOR at Black Diamond Therapeutics, Inc. · on record since Dec 19, 2022

Insider trading activity of INGRAM ROBERT ALEXANDER

Transactions on record: 738; since Sep 17, 2003

Open-market buys: 9; $4.2M

Open-market sells: 116; $9.2M

Companies traded: 14; last filing Mar 2, 2023

Figures computed from official regulatory filings — .

Companies where INGRAM ROBERT ALEXANDER has traded

33 tx · $429.5K · Mar 2, 2023
13 tx · $304.2K · Dec 19, 2022
11 tx · $307.3K · Jul 30, 2020
56 tx · $1.1M · Oct 18, 2018
115 tx · $13.1M · Apr 4, 2017
19 tx · $3.7M · Jun 7, 2016
6 tx · $4.6M · May 27, 2015
36 tx · $5.5M · May 19, 2015
201 tx · $2.5M · Oct 31, 2012
4 tx · $37.9K · Dec 6, 2011
50 tx · $1.2M · Apr 4, 2011
123 tx · $10.6M · Jun 9, 2010
47 tx · Jan 2, 2009
24 tx · $318.3K · Apr 4, 2006

Track record of INGRAM ROBERT ALEXANDER

Statistical track record

Free account

Open-market buys: 9

Last buy: Sep 30, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of INGRAM ROBERT ALEXANDER

Co-insiders of INGRAM ROBERT ALEXANDER

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 2, 2023	Award	2,259	8.85 USD	$20K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Dec 19, 2022	Award	9,375	1.50 USD	$14.1K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2022	Award	1,497	13.36 USD	$20K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Sep 19, 2022	Award	6,584	2.62 USD	$17.3K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 2, 2022	Award	1,438	13.90 USD	$20K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 17, 2022	Award	8,498	2.03 USD	$17.3K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 13, 2022	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	AwardD (derivative)	30,022	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	Award	12,866	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 2, 2022	Award	2,078	9.31 USD	$19.3K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Mar 18, 2022	Award	5,795	3.02 USD	$17.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 2, 2022	Award	1,128	16.61 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Dec 17, 2021	Award	3,296	5.31 USD	$17.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2021	Award	1,554	12.06 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Sep 23, 2021	Award	1,869	9.90 USD	$18.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 2, 2021	Award	1,177	15.92 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 22, 2021	Award	1,255	12.95 USD	$16.3K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 22, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2021	Award	1,188	15.77 USD	$18.7K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	May 27, 2021	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Black Diamond Therapeutics, Inc.Listing on record	Mar 22, 2021	Award	677	24.01 USD	$16.3K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 2, 2021	Award	1,739	10.78 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Dec 16, 2020	Award	505	34.29 USD	$17.3K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2020	Award	3,669	5.11 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Oct 1, 2020	Buy	5,000	30.46 USD	$152.3K	conv 18	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 2, 2023	Award	2,259	8.85 USD	$20K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Dec 19, 2022	Award	9,375	1.50 USD	$14.1K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2022	Award	1,497	13.36 USD	$20K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Sep 19, 2022	Award	6,584	2.62 USD	$17.3K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 2, 2022	Award	1,438	13.90 USD	$20K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 17, 2022	Award	8,498	2.03 USD	$17.3K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 13, 2022	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	AwardD (derivative)	30,022	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	Award	12,866	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 2, 2022	Award	2,078	9.31 USD	$19.3K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Mar 18, 2022	Award	5,795	3.02 USD	$17.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 2, 2022	Award	1,128	16.61 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Dec 17, 2021	Award	3,296	5.31 USD	$17.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2021	Award	1,554	12.06 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Sep 23, 2021	Award	1,869	9.90 USD	$18.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Sep 2, 2021	Award	1,177	15.92 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 22, 2021	Award	1,255	12.95 USD	$16.3K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 22, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2021	Award	1,188	15.77 USD	$18.7K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	May 27, 2021	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Black Diamond Therapeutics, Inc.Listing on record	Mar 22, 2021	Award	677	24.01 USD	$16.3K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Mar 2, 2021	Award	1,739	10.78 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Dec 16, 2020	Award	505	34.29 USD	$17.3K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 2, 2020	Award	3,669	5.11 USD	$18.7K		SEC
Black Diamond Therapeutics, Inc.Listing on record	Oct 1, 2020	Buy	5,000	30.46 USD	$152.3K	conv 18	SEC